Search

Bruker Corp

Cerrado

SectorSanidad

58.77 -2.84

Resumen

Variación precio

24h

Actual

Mínimo

56.39

Máximo

68.65

Métricas clave

By Trading Economics

Ingresos

-67M

-51M

Ventas

15M

839M

BPA

0.49

Rentabilidad por dividendo

0.35

Margen de beneficios

-6.07

Empleados

11,085

EBITDA

-71M

17M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+17.7% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

0.35%

1.96%

Fecha Próximo Dividendo

1 ene 2027

Próxima Fecha de Ex Dividendo

7 dic 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.3B

8.5B

Apertura anterior

61.61

Cierre anterior

58.77

Bruker Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 nov 2026, 21:02 UTC

News

Bruker Corporation reported Q3 revenue of $874 million, exceeding estimates, and a non-GAAP EPS of $0.56, above the expected $0.42.

3 nov 2026, 22:51 UTC

Bruker Corporation is declining in after-market trading, reaching its lowest point of the day and remaining below its 20-day moving average.

2 nov 2026, 21:04 UTC

Correlated Moves

Bruker Corporation shares are declining, continuing a downward trend since Friday's close, alongside a drop in Revvity, Inc.

31 oct 2026, 00:01 UTC

Bruker Corporation's shares were roughly flat during after-market hours on Friday, settling near the lower end of their one-month range.

30 oct 2026, 21:31 UTC

Bruker Corporation's shares have traded lower in after-market hours, retreating from an early high and near the low end of its one-month range.

29 oct 2026, 23:31 UTC

Bruker Corporation's shares are declining in after-market hours amid a broader market downturn, despite earlier recovery attempts during the session.

28 oct 2026, 19:56 UTC

Bruker Corporation shares are higher during Wednesday's session, maintaining a solid position above their 20-day moving average despite a slight retracement from an early spike.

27 oct 2026, 19:52 UTC

Bruker Corporation shares are trading higher, maintaining a position above their 20-day moving average, despite a slight pullback earlier in the session.

26 oct 2026, 19:36 UTC

Bruker Corp shares are trading modestly higher, although they remain below their 20-day moving average and near the lower end of their one-month range.

23 oct 2026, 23:06 UTC

Bruker Corp shares are advancing in after-market hours, tracking the broader market's upward movement despite mixed economic signals and rising oil prices.

22 oct 2026, 20:07 UTC

Correlated Moves

Bruker Corp shares are declining amid broader market weakness, reversing earlier gains despite positive price target upgrades from analysts.

21 oct 2026, 20:01 UTC

Bruker Corp shares are sharply higher, continuing a trend of gains since Tuesday's close amid a broader market shift in dynamics.

20 oct 2026, 21:31 UTC

News

Bruker Corp will release its Q3 2026 financial results on November 4, 2026, and hold a conference call at 8:30 a.m. EDT.

16 oct 2026, 20:07 UTC

Bruker Corp shares are declining, facing consistent selling pressure and closing significantly below the 20-day moving average amid a negative cumulative return for the day.

15 oct 2026, 20:02 UTC

Correlated Moves

Bruker Corp shares are advancing, reflecting a broader trend in the life sciences sector, amid gains in Thermo Fisher Scientific following positive analyst ratings.

14 oct 2026, 20:07 UTC

News

JPMorgan downgraded Bruker Corp from Overweight to Neutral, lowering its price target from $60 to $42, citing a reassessment of growth prospects.

13 oct 2026, 20:07 UTC

Bruker Corp shares fell, remaining near the lower end of their one-month range and below the 20-day moving average.

12 oct 2026, 20:01 UTC

Correlated Moves

Bruker Corp shares are declining amid a significant drop in 10X Genomics Inc, which has reversed a trend of higher daily closes.

8 oct 2026, 20:07 UTC

Bruker Corp shares fell sharply, continuing a three-session decline, after hitting a low shortly after the market opened and closing below the 20-day moving average.

7 oct 2026, 20:07 UTC

News
Correlated Moves

Bruker Corp's stock declined after Barclays raised its price target to $70.00, as market participants viewed the upgrade as insufficiently bullish.

6 oct 2026, 20:00 UTC

Correlated Moves

Bruker Corp shares fell sharply as the overall market declined, influenced by the performance of correlated asset 10X Genomics Inc, which is also lower.

2 oct 2026, 20:07 UTC

Bruker Corp is advancing, maintaining a strong position after closing higher since Thursday, despite pulling back slightly earlier in the session.

1 oct 2026, 19:51 UTC

Bruker Corp shares fell sharply, marking a departure from recent higher daily closes amid a broader market shift in momentum.

30 sept 2026, 21:01 UTC

Bruker Corp has declined in after-market trading, reversing earlier regular-session gains, though it remains above its 20-day moving average.

29 sept 2026, 23:11 UTC

Bruker Corp is showing an upward movement in after-market trading, with notable gains since Tuesday's close and remaining significantly above its 20-day moving average.

28 sept 2026, 20:01 UTC

News

Bruker Corporation's stock fell after an earlier gain, despite unveiling new workflows aimed at advancing drug discovery and disease research at a major conference.

25 sept 2026, 20:07 UTC

Bruker Corp shares are modestly higher, supported by a broadly advancing market, and are trading near the upper end of their one-month range.

24 sept 2026, 23:15 UTC

Bruker Corp shares are trading modestly higher in after-market hours, supported by positive economic data on jobless claims and new home sales.

23 sept 2026, 20:07 UTC

Bruker Corp's shares fell sharply after an early high, despite remaining above the 20-day moving average and near the upper end of its one-month range.

22 sept 2026, 23:01 UTC

Bruker Corp is advancing in after-market trading, reaching a peak return and remaining well above its 20-day moving average.

Comparación entre iguales

Cambio de precio

Bruker Corp previsión

Precio Objetivo

By TipRanks

17.7% repunte

Estimación a 12 Meses

Media 66.5 USD  17.7%

Máximo 80 USD

Mínimo 55 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Bruker Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

3

Comprar

2

Mantener

1

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Bruker Corp

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
help-icon Live chat